Abstract:In the realm of enzymology, Carbonic anhydrase (CA) emerges as a pivotal protagonist orchestrating the rapid conversion of carbon dioxide and water into bicarbonate ions and hydrogen ions, respectively. Carbonic anhydrase inhibitors (CAIs) are the class of drugs that target various isoforms of the enzyme, and these inhibitors play a crucial role in the treatment and management of multiple diseases such as cancer, glaucoma, high altitude sickness, rheumatoid arthritis, obesity, epilepsy, and sleep apnea. Several structural classes of CAIs developed till date possess unique architects of the pharmacophoric requirements around the central core moiety for the selective targeting of various isoforms of the CA. Recent advancements in drug design and development, along with technologies that aid in structure determination, have led to the development of several isoform-selective inhibitors of CA enzymes. However, their therapeutic utility has still not been fulfilled due to the lack of desired potency, isoform selectivity, and pharmacokinetic properties. This review covers the most recent approaches used by different researchers, which are concerned with the development of isoform-selective carbonic anhydrase inhibitors belonging to distinct structural classes like sulphonamides, carbazoles, selenols, coumarin, organotelluride, topiramate, thiophene, triazole, uracil-modified benzylic amines, and thiourea etc. In addition, their structure–activity relationships, biological evaluation, and in silico studies as well as the forthcoming avenues of advancements have been discussed. This review serves as a valuable resource for developing potent and efficacious CAIs with remarkable therapeutic implications, offering insights into their potency, specificity, and potential clinical applications.

Investigating Active Site Binding of Ligands to High and Low Activity Carbonic Anhydrase Enzymes Using Native Mass Spectrometry

Infrared Spectroscopy Reveals Metal-independent Carbonic Anhydrase Activity in Crotonyl-CoA Carboxylase/Reductase

Network of Conformational Transitions Revealed by Molecular Dynamics Simulations of the Carbonic Anhydrase II Apo-Enzyme

Comparative study of stability and activity of wild-type and mutant human carbonic anhydrase II enzymes using molecular dynamics and docking simulations

Markov-state Model for CO2 Binding with Carbonic Anhydrase under Confinement

Detachment of HCO3– from the Active Site of Carbonic Anhydrase: Molecular Dynamics Simulation and Machine Learning

Carbonic Anhydrases: Different Active Sites, Same Metal Selectivity Rules

Synthesis and Characterization of Poly(acrylic Acid‐co‐acrylamide)/hydrotalcite Nanocomposite Hydrogels for Carbonic Anhydrase Immobilization

Kinetics of CO2 Diffusion in Human Carbonic Anhydrase: a Study Using Molecular Dynamics Simulations and the Markov-state Model.

From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system

Inhibition Profiling of Human Carbonic Anhydrase II by High-Throughput Screening of Structurally Diverse, Biologically Active Compounds

Bacterial γ-carbonic anhydrases

Carbonic anhydrases: Moiety appended derivatives, medicinal and pharmacological implications

Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets

Imaging of Carbonic Anhydrase Level in Epilepsy with an Environment-Sensitive Fluorescent Probe

Intrinsic thermodynamics of sulfonamide inhibitor binding to human carbonic anhydrases I and II

Mechanism of a Novel Metal-Free Carbonic Anhydrase

Privileged Scaffold Hybridization in the Design of Carbonic Anhydrase Inhibitors

Synthesis and investigation of selective human carbonic anhydrase IX, XII inhibitors using coumarins bearing a sulfonamide or biotin moiety

Phthalazine sulfonamide derivatives as carbonic anhydrase inhibitors. Synthesis, biological and in silico evaluation

[Studies of the Physiological Function of Carbonic Anhydrase].